Access
This article is part of Nature's premium content.
Published online 19 March 2003 | Nature | doi:10.1038/news030317-3
News
Genetic test adverts under scrutiny
US government to assess impact of commercial breast-cancer campaign.
Health authorities in the United States have launched an investigation into the impact on women of an advertising campaign for a genetic breast-cancer test.
The campaign, run by biotech company Myriad Genetics, was the first to use television, radio and magazine advertising to mass-market a genetic test.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
